Dan Donovan

Dan Donovan is an experienced entrepreneur and executive in the biopharmaceutical and healthcare sectors. As Founder and CEO of rareLife solutions since October 2014, Donovan leads efforts to modernize the development and commercialization of products for rare diseases. Donovan also serves on the Board of Directors for Intensity Therapeutics and Panbela Therapeutics, contributing to innovative approaches in cancer treatment and therapeutic development. In addition, Donovan founded WestportBoys, an investment syndicate focused on private investment opportunities, and held the position of Chief Business Officer at Cancer Prevention Pharmaceuticals, overseeing the development of prevention therapies. Prior roles include Senior Vice President at United BioSource Corporation and Founder and President of Envision Pharma. Donovan began the professional career at Pfizer, where extensive experience was gained in various marketing roles. Educational background includes a BS in Finance and Business from Lehigh University.